Order Article Reprints

Armstrong ND, Srinivasasainagendra V, Chekka LMS, Nguyen NHK, Nahid NA, Jones AC, Tanner RM, Hidalgo BA, Limdi NA, Claas SA, et al. Genetic Contributors of Efficacy and Adverse Metabolic Effects of Chlorthalidone in African Americans from the Genetics of Hypertension Associated Treatments (GenHAT) Study. Genes. 2022; 13(7):1260. https://doi.org/10.3390/genes13071260

Armstrong, Nicole D., Vinodh Srinivasasainagendra, Lakshmi Manasa S. Chekka, Nam H. K. Nguyen, Noor A. Nahid, Alana C. Jones, Rikki M. Tanner, Bertha A. Hidalgo, Nita A. Limdi, Steven A. Claas, and et al. 2022. "Genetic Contributors of Efficacy and Adverse Metabolic Effects of Chlorthalidone in African Americans from the Genetics of Hypertension Associated Treatments (GenHAT) Study" Genes 13, no. 7: 1260. https://doi.org/10.3390/genes13071260

Armstrong, N. D., Srinivasasainagendra, V., Chekka, L. M. S., Nguyen, N. H. K., Nahid, N. A., Jones, A. C., Tanner, R. M., Hidalgo, B. A., Limdi, N. A., Claas, S. A., Gong, Y., McDonough, C. W., Cooper-DeHoff, R. M., Johnson, J. A., Tiwari, H. K., Arnett, D. K., & Irvin, M. R. (2022). Genetic Contributors of Efficacy and Adverse Metabolic Effects of Chlorthalidone in African Americans from the Genetics of Hypertension Associated Treatments (GenHAT) Study. Genes, 13(7), 1260. https://doi.org/10.3390/genes13071260